rss
J Clin Pathol 55:154-155
  • Short report

Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy

Table 1

Age related varicella zoster virus antibody prevalence

Year of survey
Age of cohort (years) 1966 1970 1974 1978 1984 1988 1992
Figures in parenthesis are percentages.
1–4 1/14 (7) 2/46 (4) 11/54 (20) 3/12 (25) 5/21 (24) 8/34 (24) 37/73 (51)
5–9 18/32 (56) 24/37 (65) 23/43 (53) 9/30 (30) 24/43 (56) 9/26 (35) 23/36 (64)
10–19 4/6 (67) 40/40 (100) 23/28 (83) 37/47 (79) 31/39 (79) 51/58 (88) 44/46 (96)
20–29 48/49 (98) 66/67 (99) 45/48 (94) 43/48 (90) 50/55 (91) 49/53 (92)
30–39 31/31 (100) 41/45 (91) 46/47 (98) 22/30 (73) 49/52 (94) 52/54 (96)

This Article

Latest from JCP Education

Latest from JCP Education

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Latest Pathology jobs

    Latest Pathology jobs